GERG-CIDM-001 · UQG-006
Why is the Influenza / respiratory viruses × Whole-genome sequencing relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Influenza whole-genome/genomic sequencing is an established global surveillance capability; the remaining iCIDM issue is representation/capability-history calibration rather than whether the relationship exists scientifically.
Next state: U1_REPRESENTATION_UNKNOWN
Next action: Return to classification/detector calibration; reformulate as CIDM adoption/capability-history question if useful.
Public evidence: CDC influenza genetic characterization · WHO/GISRS genomics context
GERG-CIDM-002 · UQG-008
Why is the Influenza / respiratory viruses × Bioinformatics / modelling relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Bioinformatics and modelling are long-established components of influenza surveillance, evolution analysis and vaccine-strain work. The stronger remaining question is how CIDM's documented capability compares with global practice.
Next state: U1_U4_REFORMULATE
Next action: Reformulate from existence question to comparative institutional capability/adoption question.
Public evidence: PubMed: bioinformatics/computational biology in influenza · WHO GISRS bioinformatics workshop
GERG-CIDM-003 · UQG-009
The Streptococcus pneumoniae × PCR / molecular diagnostics relationship was recurrent but has not appeared recently in the corpus. Is the capability obsolete, absorbed into newer methods, dormant, or simply relabelled?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: PCR-based pneumococcal detection/serotyping is an established global diagnostic/surveillance capability. The iCIDM question should focus on local historical continuity, relabelling, replacement or documentation rather than whether the method is scientifically established.
Next state: U1_U4_REFORMULATE
Next action: Trace CIDM historical method labels and later replacement technologies; do not promote original existence-gap question.
Public evidence: CDC pneumococcal PCR and serotyping · PubMed pneumococcal PCR clinical study
GERG-CIDM-004 · UQG-001
Why is the Cryptococcus × Whole-genome sequencing relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Whole-genome/population genomics is well established for clinical Cryptococcus isolates and global population structure. The original existence-gap question should close; the useful CIDM question is local adoption, contribution, coverage, or representation.
Next state: U1_REPRESENTATION_OR_LOCAL_CAPABILITY_HISTORY
Next action: Reformulate toward CIDM historical contribution/adoption and inspect local classification coverage.
Public evidence: PubMed: 372 clinical Cryptococcus isolates, WGS/population genetics · PubMed: Cryptococcus population genomics, Brazil · PubMed: C. gattii phylogenomics/WGS
GERG-CIDM-005 · UQG-002
Why is the Arboviruses × Clinical trial / therapy relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
PARTIALLY_RESOLVED_GLOBALLY_AND_TOO_BROAD
Resolution: Clinical management and therapeutic research clearly exist globally across arboviral diseases, but 'arboviruses' mixes distinct diseases with different evidence, vaccines and treatment gaps. The broad relationship question is not a useful U5 question.
Next state: U2_MIXED_REALITY_PLUS_U4_REFORMULATE
Next action: Split by dengue/chikungunya/Zika/yellow fever and by supportive care, antiviral therapy, vaccine, severe-disease management, then search each narrower question.
Public evidence: WHO 2025 integrated arboviral clinical management guideline · NCBI Bookshelf: WHO arboviral guideline
GERG-CIDM-006 · UQG-003
Why is the Aspergillus × Whole-genome sequencing relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Whole-genome and population genomic approaches are well established for Aspergillus, including clinical/environmental A. fumigatus isolates, azole resistance, species identification and population structure.
Next state: U1_REPRESENTATION_OR_LOCAL_CAPABILITY_HISTORY
Next action: Close the global existence question; reformulate around CIDM/Australian contribution, clinical translation, resistance prediction or corpus representation.
Public evidence: PubMed: A. fumigatus population genomics and azole resistance · PubMed: clinical/environmental A. fumigatus WGS · PubMed: fungal WGS clinical identification
GERG-CIDM-007 · UQG-004
Why is the Staphylococcus aureus / MRSA × Serology / immunology relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
PARTIALLY_RESOLVED_GLOBALLY_REFORMULATE
Resolution: Serologic/antibody approaches to S. aureus infection have a long literature, so the relationship itself is not globally absent. However, routine modern diagnostic value and the exact MRSA-specific role are narrower questions and may differ from historical immunology research.
Next state: U4_PARTIAL_GLOBAL_RESOLUTION
Next action: Reformulate to a precise use-case: historical serodiagnosis, immune correlates, vaccine/antibody research, or current clinical diagnostic utility.
Public evidence: PubMed: S. aureus serological assays · PubMed: antibody diagnosis of S. aureus endocarditis · PubMed: teichoic-acid antibody ELISA
GERG-CIDM-008 · UQG-005
Why is the Bordetella pertussis × Clinical trial / therapy relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Pertussis treatment and prophylaxis are globally established, with randomized antibiotic trials, systematic-review evidence and current clinical guidance. Remaining questions concern timing, resistance, severe disease and improved therapies rather than whether a therapy relationship exists.
Next state: U1_U4_REFORMULATE
Next action: Close original existence-gap question; reformulate toward resistance, treatment timing, clinical outcomes or local CIDM role.
Public evidence: CDC pertussis treatment guidance · PubMed: antibiotics for pertussis trials/review · PubMed: randomized clarithromycin vs erythromycin trial
GERG-CIDM-009 · UQG-007
Why is the Streptococcus pneumoniae × Bioinformatics / modelling relationship sparse in the publication corpus, and is this a true capability gap, a terminology/classification gap, or simply an unrepresented relationship?
SUBSTANTIALLY_RESOLVED_GLOBALLY
Resolution: Pneumococcal bioinformatics, pan-genomics, population genomics and epidemiological modelling are mature global research areas. The original existence-gap question should close.
Next state: U1_REPRESENTATION_OR_LOCAL_CAPABILITY_HISTORY
Next action: Reformulate to CIDM-specific adoption, distinctive contribution, local datasets or missing computational capability documentation.
Public evidence: PubMed: 26,306 pneumococcal genomes and clustering/bioinformatics · PubMed: pneumococcal pan-genome/population genetics review · PubMed: Pneumo Wiki pan-genome database